RecallDepth
Class II Terminated

BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1

Company
Tailstorm Health Inc
Recall Initiated
November 6, 2024
Posted
November 27, 2024
Recall Number
D-0051-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
27,560 Syringes
Firm Location
Phoenix, AZ, United States

Reason for Recall

Lack of Sterility Assurance

Distribution

Nationwide Within U.S.

Lot / Code Info

Lot #: D24005, Exp. Date 20 February 2025; D24006, Exp. Date 21 February 2025; D24007, Exp. Date 22 February 2025; D24008, Exp. Date 19 March 2025; D24009, Exp. Date 20 March 2025; D24012, Exp. Date 25 April 2025.

More recalls by Tailstorm Health Inc

View all recalls by this company →

Other recent Class II Drug recalls